NSD1 and head and neck neoplasm: In particular, while a subset of HPV-negative HNSCC, primarily laryngeal carcinoma with NSD1 loss of function mutations, has a favorable prognosis (9), this represents only a minority of HNSCC, while >80% HPV-negative head and neck tumors are NSD1-wild type.